An old drug with new tricks: Exploring the cancer-fighting promise and limitations of hydroxychloroquine

As the hunt for effective cancer therapies intensifies, some scientists are turning back to look at old drugs in a new light. The anti-malarial hydroxychloroquine is one such drug that has been “repurposed” to fight cancer. Despite its effectiveness at blocking the resupply of needed resources to cancer cells, clinical trial results have been disappointing, in part because cancer cells eventually become resistant to the drug.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup